Irritable Bowel Syndrome and Drospirenone-Containing Oral Contraceptives; A Comparative-Safety Study
Steven T. Bird(United States Food and Drug Administration), Mahyar Etminan(Oncolytics Biotech (Canada)), James M. Brophy(McGill University Health Centre), Joseph A. Delaney(Center for Drug Evaluation and Research), Brian Bressler(University of British Columbia), Wei Liu(Guangxi Medical University)
Cited by 8
Related Papers
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
Rates of New or Missed Colorectal Cancers After Colonoscopy and Their Risk Factors: A Population-Based Analysis
|Gastroenterology|2007|627
Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data
|BMJ|2017|525
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
|Gastroenterology|2015|478